Bluejay Diagnostics, Inc. (BJDX)
NASDAQ: BJDX · IEX Real-Time Price · USD
0.550
-0.075 (-12.02%)
At close: Apr 24, 2024, 3:16 PM
0.610
+0.060 (10.93%)
After-hours: Apr 24, 2024, 5:36 PM EDT
Bluejay Diagnostics Market Cap
Bluejay Diagnostics has a market cap or net worth of $1.48 million as of April 24, 2024. Its market cap has decreased by -80.02% in one year.
Market Cap
1.48M
Enterprise Value
-377.16K
1-Year Change
-80.02%
Ranking
Category
Stock Price
$0.55
Market Cap Chart
Since the IPO on November 10, 2021, Bluejay Diagnostics's market cap has decreased from $126.38M to $1.48M, a decrease of -98.83%. That is a compound annual growth rate of -83.70%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 23, 2024 | 1.70M | - |
Apr 22, 2024 | 1.70M | 13.33% |
Apr 19, 2024 | 1.50M | - |
Apr 18, 2024 | 1.50M | - |
Apr 17, 2024 | 1.50M | - |
Apr 16, 2024 | 1.50M | -6.25% |
Apr 15, 2024 | 1.60M | -5.88% |
Apr 12, 2024 | 1.70M | -5.56% |
Apr 11, 2024 | 1.80M | - |
Apr 10, 2024 | 1.80M | 5.88% |
Apr 9, 2024 | 1.70M | - |
Apr 8, 2024 | 1.70M | -5.56% |
Apr 5, 2024 | 1.80M | -5.26% |
Apr 4, 2024 | 1.90M | - |
Apr 3, 2024 | 1.90M | -5.00% |
Apr 2, 2024 | 2.00M | -4.76% |
Apr 1, 2024 | 2.10M | -4.55% |
Mar 28, 2024 | 2.20M | 120.00% |
Mar 27, 2024 | 1.00M | - |
Mar 26, 2024 | 1.00M | - |
Mar 25, 2024 | 1.00M | - |
Mar 22, 2024 | 1.00M | - |
Mar 21, 2024 | 1.00M | - |
Mar 20, 2024 | 1.00M | - |
Mar 19, 2024 | 1.00M | - |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
LogicMark | 1.91M |
Ensysce Biosciences | 1.73M |
InMed Pharmaceuticals | 1.73M |
180 Life Sciences | 1.70M |
Tivic Health Systems | 1.66M |
TC Biopharm (Holdings) | 1.57M |
NeuBase Therapeutics | 1.52M |
Virax Biolabs Group | 1.47M |